Clive Anderson

Eisai EMEA

Welcome to the Eisai EMEA. Eisai (pronounced 'ā-zī') is derived from the Japanese word for 'health product'​ and, here at Eisai, we discover, develop and market innovative, high quality medicines throughout the world. Eisai is one of the world's leading research-based pharmaceutical companies. We define our corporate mission as "giving first thought to patients and their families, and to increasing the benefits health care provides,"​ which we call human health care (hhc). With operations in the U.S., Asia, Europe, Russia, India, Africa, the Middle East, Australia and it's domestic home market of Japan, Eisai employs more than 11,000 people worldwide. Our main focuses are within Oncology & Neurology (dementia-related diseases and neurodegenerative diseases).